In type 1 diabetes, real-time vs. intermittently scanned continuous glucose monitoring improved glycemic control

Ann Intern Med. 2021 Oct;174(10):JC119. doi: 10.7326/ACPJ202110190-119. Epub 2021 Oct 5.

Abstract

Visser MM, Charleer S, Fieuws S, et al. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Lancet. 2021;397:2275-83. 34089660.

Publication types

  • Comment

MeSH terms

  • Adult
  • Blood Glucose
  • Blood Glucose Self-Monitoring
  • Diabetes Mellitus, Type 1* / drug therapy
  • Glycemic Control
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Prospective Studies

Substances

  • Blood Glucose
  • Hypoglycemic Agents